Peramivir + Placebo Comparator
Phase 3Terminated 0 watching 0 views this week📈 Rising
72
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Influenza
Conditions
Influenza
Trial Timeline
Oct 1, 2010 → Nov 1, 2010
NCT ID
NCT01224795About Peramivir + Placebo Comparator
Peramivir + Placebo Comparator is a phase 3 stage product being developed by BioCryst Pharmaceuticals for Influenza. The current trial status is terminated. This product is registered under clinical trial identifier NCT01224795. Target conditions include Influenza.
Hype Score Breakdown
Clinical
27
Activity
18
Company
5
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01224795 | Phase 3 | Terminated |
Competing Products
20 competing products in Influenza